Seth Klarman’s Celgene Corp CELG Stock Holding History

Seth Klarman’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,000,000	Closed	-$377M	–	36
2019 Q1	$377M	Buy	+4,000,000	New	+$350M	3.17%	11

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Seth Klarman's CELG Position: Q2 2019 in Review

Seth Klarman sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 4,000,000 shares — an estimated $377M sold.

Seth Klarman first reported a position in CELG in Q1 2019 and held it in 1 quarter. The position peaked at $377M in Q1 2019. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Seth Klarman reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Seth Klarman sold 4,000,000 Celgene Corp shares in Q2 2019, an estimated $377M.
Seth Klarman first reported a position in Celgene Corp in Q1 2019 and held it in 1 quarter.
Seth Klarman's Celgene Corp position peaked at $377M in Q1 2019.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Baupost Group's 13F filing for Q2 2019, filed 13 Aug 2019.